Brookdale Senior Living Inc. (BKD) Stock
Key stats
- Market cap
- $2.21B
- Price / Earnings ratio
- -59.9x
- EPS (TTM)
- -$0.16
- Volume
- Loading
- 52-week high
- $17.09
- 52-week low
- $8.79
Source: third-party data provider, as of November 13, 2026
Compare with BKD
Recent news

Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?
Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?
BKD

Are Medical Stocks Lagging Brookdale Senior Living (BKD) This Year?
Are Medical Stocks Lagging Brookdale Senior Living (BKD) This Year?
BKD

Down 17.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Brookdale (BKD)
Down 17.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Brookdale (BKD)
BKD

Brookdale Senior Living Q2 Earnings Call Highlights
Brookdale Senior Living Q2 Earnings Call Highlights
BKD
Technical indicators
- RSI 14
- 37.62
- MACD 12/26/9
- -0.33
- EMA 9 of MACD
- -0.27
- MACD histogram
- -0.06
- SMA 50
- $10.74
- Price below SMA 50
- EMA 50
- $10.76
- Price below EMA 50
- SMA 200
- $13.23
- Price below SMA 200
- EMA 200
- $12.24
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market has no earnings per share expectations for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?
Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?
BKD

Are Medical Stocks Lagging Brookdale Senior Living (BKD) This Year?
Are Medical Stocks Lagging Brookdale Senior Living (BKD) This Year?
BKD

Down 17.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Brookdale (BKD)
Down 17.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Brookdale (BKD)
BKD

Brookdale Senior Living Q2 Earnings Call Highlights
Brookdale Senior Living Q2 Earnings Call Highlights
BKD

Can Higher Occupancy Help Brookdale Senior Narrow Q2 Losses?
Can Higher Occupancy Help Brookdale Senior Narrow Q2 Losses?
BKD

Brookdale Senior Q2'26 Sneak Peek: Occupancy Volume Rises to 82.4%
Brookdale Senior Q2'26 Sneak Peek: Occupancy Volume Rises to 82.4%
BKD

Brookdale Senior May 2026 Occupancy Volume Rises to 82.5%
Brookdale Senior May 2026 Occupancy Volume Rises to 82.5%
BKD

Brookdale Senior Living Q1 Earnings Call Highlights
Brookdale Senior Living Q1 Earnings Call Highlights
BKD

Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?
Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?
BKD

Brookdale Senior Q1'26 Sneak Peek: Occupancy Volume Rises to 82.1%
Brookdale Senior Q1'26 Sneak Peek: Occupancy Volume Rises to 82.1%
BKD
About Brookdale Senior Living Inc.
Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Nikolas W. Stengle | CEO & Director | 1977 |
| Ms. Dawn L. Kussow CPA | Executive VP & CFO | 1974 |
| Mr. Chad C. White | Executive VP, General Counsel & Secretary | 1975 |
| Ms. Jaclyn C. Pritchett | Executive VP & Chief Human Resources Officer | 1985 |
| Mr. Michael Grant | Vice President of Investor Relations | — |
| Mr. David Cygan | Chief Marketing Officer | — |
| Mr. Teddy Hillard | Senior Vice President of Corporate Development | — |
| Ms. Margaret Cabell | Chief Sales Officer | — |
| Mr. Clark Jones | Senior Vice President of Strategic Operations | — |
| Ms. Camille Jordan | Senior VP & Chief Clinical Officer | — |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 37.62
- MACD 12/26/9
- -0.33
- EMA 9 of MACD
- -0.27
- MACD histogram
- -0.06
- SMA 50
- $10.74
- Price below SMA 50
- EMA 50
- $10.76
- Price below EMA 50
- SMA 200
- $13.23
- Price below SMA 200
- EMA 200
- $12.24
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $12.00
- Average
- $13.00
- High
- $14.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -15.8 | -9.3 | ||||||||||
| 2022 | -0.4 | +25.5 | +4.9 | -15.7 | -7.6 | -20.1 | +6.4 | -7.9 | -4.3 | +0.4 | -28.6 | -13.9 |
| 2023 | +4.7 | +11.0 | -7.8 | +46.4 | -18.2 | +24.5 | -17.2 | +13.3 | -3.7 | +3.2 | +35.2 | +8.8 |
| 2024 | -4.4 | +0.5 | +18.7 | +0.7 | -4.3 | +1.6 | +8.3 | -6.9 | -4.0 | -5.0 | -9.1 | -9.9 |
| 2025 | -8.5 | +24.2 | +11.0 | +7.4 | -0.9 | +9.3 | +13.1 | +1.2 | +9.9 | +8.3 | +21.4 | -2.6 |
| 2026 | +38.4 | -2.2 | -9.6 | +3.6 | -10.1 | +32.0 | -7.7 | -18.0 | -9.0 | -4.2 | -11.7 |



